BioLife Solutions, Inc. Accrued Liabilities, Current
BioLife Solutions, Inc. (BLFS) had Accrued Liabilities, Current of $2.70 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-06
- 2026-06-30: Accrued Liabilities, Current $2.70M.
- 2026-03-31: Accrued Liabilities, Current $3.26M.
- 2025-12-31: Accrued Liabilities, Current $5.85M.
- 2025-09-30: Accrued Liabilities, Current $5.91M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $2.70M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $3.26M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $5.85M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $5.91M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $4.96M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $4.34M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $7.19M 10-K · filed 2026-02-26 | $7.12M 10-K · filed 2025-03-03 |
| 2024-09-30 | $2.86M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $2.80M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $4.25M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $6.62M 10-K · filed 2025-03-03 | $6.91M 10-K · filed 2024-02-29 |
| 2023-09-30 | $3.70M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $3.67M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $3.83M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $3.13M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $1.47M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $1.95M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $1.37M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $1.66M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $1.44M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $978.00K 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $323.00K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $472.00K 10-K · filed 2022-03-31 | |
| 2020-09-30 | $3.36M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $2.61M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $3.08M 10-Q · filed 2020-05-29 | |
| 2019-12-31 | $301.00K 10-K · filed 2021-03-31 | $3.37M 10-K · filed 2020-05-15 |
| 2019-09-30 | $642.00K 10-K · filed 2020-05-15 | |
| 2019-06-30 | $204.00K 10-K · filed 2020-05-15 | |
| 2019-03-31 | $142.00K 10-K · filed 2020-05-15 | |
| 2018-12-31 | $1.22M 10-K · filed 2020-05-15 | $91.00K 10-K · filed 2019-03-15 |
| 2018-09-30 | $162.00K 10-K · filed 2020-05-15 | $162.98K 10-Q · filed 2018-11-08 |
| 2018-06-30 | $173.00K 10-K · filed 2020-05-15 | $172.88K 10-Q · filed 2018-08-09 |
| 2018-03-31 | $204.00K 10-K · filed 2020-05-15 | $202.78K 10-Q · filed 2018-05-11 |
| 2017-12-31 | $201.00K 10-K · filed 2019-03-15 | $200.55K 10-K · filed 2018-03-09 |
| 2017-09-30 | $170.42K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $63.62K 10-Q · filed 2017-08-11 | |
| 2017-03-31 | $69.33K 10-Q · filed 2017-05-12 | |
| 2016-12-31 | $116.40K 10-K · filed 2018-03-09 | |
| 2016-09-30 | $50.61K 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $80.04K 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $113.34K 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $146.44K 10-K · filed 2017-03-15 | |
| 2015-09-30 | $150.98K 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $62.74K 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $160.90K 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $121.87K 10-K · filed 2016-02-25 | |
| 2014-09-30 | $90.47K 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $10.44K 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $30.04K 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $146.63K 10-K · filed 2015-03-12 | |
| 2013-09-30 | $52.53K 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $51.82K 10-Q · filed 2013-08-12 | |
| 2013-03-31 | $19.98K 10-Q · filed 2013-05-14 | |
| 2012-12-31 | $8.49K 10-K · filed 2014-02-12 | |
| 2012-09-30 | $149.61K 10-Q · filed 2012-11-13 | |
| 2012-06-30 | $126.22K 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $58.21K 10-Q · filed 2012-05-14 | |
| 2011-12-31 | $69.58K 10-K · filed 2013-03-29 | |
| 2011-09-30 | $100.44K 10-Q · filed 2011-11-14 | |
| 2010-12-31 | $108.02K 10-K · filed 2012-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |